Companies/Body and Mind Inc.

Company profile

Body and Mind Inc.

OTC: BMMJ · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCCIK 0001715611Reports USD

#528 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ 26GM —SS 49

v0.1 · 25/100 weight · pillars only

↑ 3-yr revenue growth, workforce scale · ↓ filing timeliness, market scale

Methodology →

Revenue TTM

$14.3M

Rev growth YoY (TTM)

-48.9%

Net income (FY)

-$20.6M

Employees

142

Market cap

$14.8k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$22.8M$22.8M2023

Net income-$20.6M-$20.6M2023

Operating income-$7.7M-$7.7M2023

Total assets$21.2M$21.2M2023

Liabilities$30.5M$30.5M2023

Equity-$10.3M-$10.3M2023

Revenue trend

FY2018 – FY2023 · USD

$2.7M

FY18

$5.3M

FY19

$6.2M

FY20

$26.9M

FY21

$31.6M

FY22

$22.8M

FY23

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Body and Mind Inc. booked $22.8M in FY2023 revenue, contracting 28% year over year — slower than 75% of Healthcare companies we track, at a -90.1% net margin.

Peers · Healthcare

VioQuest Pharmaceuticals, Inc.——Stemtech Corporation25D CERo Therapeutics Holdings, Inc.——Halo Collective Inc.——

Key facts

CEOMichael Mills

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: BMMJ

Employees142

IPO date2012-02-22

Latest filings

8-K2025-09-05 8-K2025-08-13 8-K2025-06-12 8-K2025-04-23 8-K2025-04-09 8-K2025-02-06 8-K2025-02-03 8-K2025-01-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.